A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)
Clinical trial NCT02694328 · COMPLETED
Trial details
- NCT number
- NCT02694328
- Sponsor
- Alkermes, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-02
- Primary completion
- 2018-11-07
- Enrollment
- 561
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.